If anything, anti-GARP:TGF-β1 mAbs tend to protect Il22r−/− mice against severe intestinal disease and mortality induced by C. rodentium infection, although differences by comparison to PBS controls were not always statistically significant (Fig. 1c, supplementary Fig. 1b, and Fig. 2a). The gene discussed is TGFB1; the disease is intestinal disorder.